L-Theanine for Relaxation and Mood in Cancer Surveillance
Survey Administration
+ Theanine
Supportive Care Study
Summary
Study start date: April 1, 2026
Actual date on which the first participant was enrolled.This study focuses on exploring the effects of L-theanine, a compound found in tea, on relaxation and mood among cancer patients who are under surveillance but not actively undergoing treatment. The main goal is to see if taking L-theanine is practical for these patients and if it helps improve their relaxation and mood. The study aims to find out if a daily dose of 200mg once or twice can make a significant difference. This research is important because managing stress and mood can be challenging for cancer patients, and finding a simple supplement like L-theanine that might help can improve their quality of life. Participants in this study are randomly assigned to one of two groups. One group takes L-theanine orally once a day, while the other takes it twice a day, for a period of six weeks. Researchers use various scales to measure changes in relaxation, anxiety, and mood, such as the Visual Analog Scale and the Profile of Mood States. They also look at sleep quality and any side effects that might occur. After the six-week period, participants have a follow-up check 14 days later to assess any ongoing effects or changes. The study also assesses how easy it is to recruit and keep participants engaged throughout the trial.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.50 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Supportive Care Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalGroup II
ExperimentalStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 4 locations
City of Hope Seacliff
Huntington Beach, United StatesCity of Hope at Irvine Lennar
Irvine, United StatesCity of Hope at Irvine Sand Canyon
Irvine, United States